Eyenuk Wins Juniper Research Digital Health Innovation Award for Best Digital Diagnostic Solution

“We are honored that the watch you AI System was selected as the ‘Best Digital Diagnostic Solution’ by Juniper Research,” said Kaushal Solanki, Ph.D., founder and CEO of Eyenuk. “The Eyenuk AI platform is being developed with the goal of screening all of the world’s eyes for vision-threatening and chronic diseases. This recognition furthers our commitment to expanding access to early, on-the-spot disease detection while improves accuracy and reduces costs.”

Traditional diabetic retinopathy (DR) screening requires an eye care specialist to dilate a patient’s eyes and examine the back of the eyes, a costly process that requires long waits for appointments and prevents specialists from focus on patients who need treatment. Although early detection and treatment of DR can reduce the risk of blindness by 95%1up to 50% of Americans with diabetes do not get their annual eye examtwomaking DR the leading cause of blindness among working-age adults.

the watch you The platform solves these problems by making DR detection more accessible while improving efficiency, accuracy, and cost. For the first time, fully autonomous, real-time DR screening can be performed by non-specialists in primary care practices, diabetes centers, and other front-line care settings during a patient’s routine office visit with highly responsive results. Accurate data available in seconds. Positive cases are referred to eye care specialists, ensuring your time is optimized to evaluate and treat complex cases. FDA approved watch you AI System is the most widely validated AI technology for autonomous DR detection, tested on more than 500,000 patients worldwide with 2 million images collected in clinical settings.

“Early adopters have told us that the watch you The system is a true clinical game changer, making real-time DR screening possible in point-of-care settings by freeing up eye care professionals to focus on more complex clinical tasks,” he said. frank cheng, president and commercial director of Eyenuk. “We are extremely proud to be recognized by Juniper Research as an innovator and disruptor in the industry as we continue to develop products for additional disease indications.”

Consistently outperforming competitors in independent benchmark studies, the high performance watch you The system is currently used by more than 100 organizations worldwide to improve patient access and health equity and prevent vision loss due to DR.

About Eyenuk, Inc.

Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and a leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance . Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of vision and life-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, risk of stroke, risk cardiovascular disease and Alzheimer’s disease. Find Eyenuk online on his website, TwitterFacebook and LinkedIn.

About watch you AI system

the watch you AI System provides fully autonomous Diabetic Retinopathy (DR) screening, including retinal imaging, DR screening based on international clinical standards, and immediate reporting, in a single office visit during a diabetic patient’s regular exam. Once the patient’s fundus images have been captured and sent to the watch you AI System, DR detection results are available in a PDF report in less than 30 seconds.

the watch you AI System was developed with funding from the US National Institutes of Health (NIH) and is validated by the UK National Health Service (NHS). In addition to 510(k) clearance from the US Food and Drug Administration (FDA), the watch you AI System is CE marked as a class 2a medical device in the European Union and licensed by Health Canada. It is designed to comply with the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act of 1996 (HIPAA).

the watch you AI System is reimbursable by government and private payers in the US under the newly created Category 1 Current Procedural Terminology (CPT) code 92229.

VIDEO: Learn more about the watch you AI System for the Autonomous Detection of Diabetic Retinopathy

Media contact
Todd Stein
+1 510 417 0612
[email protected]

Eyenuk, Inc. Contact
frank chengPresident and CCO
+1 818 835 3585
[email protected]

References:

  1. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-eye-disease
  2. https://www.cdc.gov/visionhealth/basics/ced/index.html

SOURCE Eyenuk

Leave a Comment